SCHEMBL1206901

SCHEMBL1206901

CCCCc1ccc(/C=C/C(=O)O)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.63
HPGD P15428 3/20 0.63
KDM4E B2RXH2 2/20 0.63
SMN1; SMN2 Q16637 2/20 0.63
NPC1 O15118 1/20 0.63
CASP3 P42574 1/20 0.63
RAB9A P51151 1/20 0.63
SENP8 Q96LD8 1/20 0.63
SENP7 Q9BQF6 1/20 0.63
SENP6 Q9GZR1 1/20 0.63
ATG4B Q9Y4P1 12/20 0.58
PLA2G1B P04054 11/20 0.58
THRA P10827 2/20 0.56
THRB P10828 2/20 0.56
CYP1A2 P05177 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
RECQL P46063 1/20 0.56
HSD17B10 Q99714 1/20 0.56
MITF O75030 1/20 0.56
KLF5 Q13887 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1206905 1.00 ALDH1A1 (0.63) ALDH1A1HPGDKDM4ESMN1; SMN2NPC1
SCHEMBL28614845 1.00 ALDH1A1 (0.63) ALDH1A1HPGDKDM4ESMN1; SMN2NPC1
Hydrochloric Acid SCHEMBL11763070 0.98 ALDH1A1 (0.61) ALDH1A1HPGDKDM4ESMN1; SMN2NPC1
SCHEMBL846032 0.95 ALDH1A1 (0.69) ALDH1A1HPGDKDM4ESMN1; SMN2NPC1
SCHEMBL846033 0.95 ALDH1A1 (0.69) ALDH1A1HPGDKDM4ESMN1; SMN2NPC1
SCHEMBL6287182 0.93 ALDH1A1 (0.67) ALDH1A1HPGDKDM4ESMN1; SMN2NPC1
Hydrochloric Acid SCHEMBL11766313 0.93 ALDH1A1 (0.67) ALDH1A1HPGDKDM4ESMN1; SMN2NPC1
SCHEMBL489898 0.93 ALDH1A1 (0.67) ALDH1A1HPGDKDM4ESMN1; SMN2NPC1
SCHEMBL6279559 0.93 ALDH1A1 (0.67) ALDH1A1HPGDKDM4ESMN1; SMN2NPC1
SCHEMBL11765995 0.93 ALDH1A1 (0.67) ALDH1A1HPGDKDM4ESMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5961875-A Antifreeze/coolant composition containing cinnamic acid CCI CO., LTD. (JP) 1999-10-05 US claimed
US-11253596-B2 Phenylalkylcarboxylic acid delivery agents NOVO NORDISK NORTH AMERICA OPERATIONS A/S (DK) 2022-02-22 US disclosed
US-20200405863-A1 PHENYLALKYLCARBOXYLIC ACID DELIVERY AGENTS NOVO NORDISK A/S (DK) 2020-12-31 US disclosed
US-10456472-B2 Phenylalkylcarboxylic acid delivery agents EMISPHERE TECHNOLOGIES, INC. (US) 2019-10-29 US disclosed
EP-2114145-B1 PHENYLALKYLCARBOXYLIC ACID DELIVERY AGENTS EMISPHERE TECH INC (US) 2017-11-01 EP disclosed
US-20160375135-A1 PHENYLALKYLCARBOXYLIC ACID DELIVERY AGENTS EMISPHERE TECHNOLOGIES, INC. (US) 2016-12-29 US disclosed
US-9150510-B2 Amino acid derivative NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 2015-10-06 US disclosed
EP-1888596-B1 SUBSTITUTED SPIRO COMPOUNDS AND THEIR USE FOR PRODUCING PAIN-RELIEF MEDICAMENTS GRUENENTHAL GMBH (DE) 2014-10-22 EP disclosed
US-8772307-B2 Substituted spiro compounds and their use for producing pain-relief medicaments GRUENENTHAL GMBH (DE) 2014-07-08 US disclosed
US-8772307-B2 Substituted spiro compounds and their use for producing pain-relief medicaments GRUENENTHAL GMBH (DE) 2014-07-08 US disclosed
EP-0864629-B1 Antofreeze/coolant composition CCI KK (JP) 2004-03-03 EP disclosed
US-20030144338-A1 Tyrosine phosphatase inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2003-07-31 US disclosed
EP-1284260-A1 TYROSINE PHOSPHATASE INHIBITORS Takeda Chemical Industries, Ltd. (JP) 2003-02-19 EP disclosed
US-5961875-A Antifreeze/coolant composition containing cinnamic acid CCI CO., LTD. (JP) 1999-10-05 US disclosed
EP-0864629-A1 Antofreeze/coolant composition CCI Co. Limited (JP) 1998-09-16 EP disclosed
US-RE32944-E Aromatic carboxylic amide derivatives Kissei Yakuhin Kogyo Kabushiki (JP) 1989-06-06 US disclosed
US-4070484-A Antiallergic composition containing aromatic carboxylic amide derivatives and method of using the same KISSEI PHARMACEUTICAL CO., LTD. (JA) 1978-01-24 US disclosed
US-4061587-A Liquid crystalline cinnamic acid esters HOFFMANN-LA ROCHE INC. (US) 1977-12-06 US disclosed
US-3962219-A DISTYRYL-BENZOBISOXAZOLES BAYER AKTIENGESELLSCHAFT (DT) 1976-06-08 US disclosed
US-3940422-A ANTIALLERGEN KISSEI YAKUHIN KOGYO KABUSHIKI KAISHA (JA) 1976-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030144338-A1 Tyrosine phosphatase inhibitors PTPRC, PTPN1, PTPRM ALDH1A1 2470/4885HPGD 4399/4885KDM4E 171/4885
US-20200405863-A1 PHENYLALKYLCARBOXYLIC ACID DELIVERY AGENTS PGF, LIPA, PDGFA ALDH1A1 599/4885HPGD 1242/4885KDM4E 2723/4885
US-10456472-B2 Phenylalkylcarboxylic acid delivery agents PGF, LIPA, PDGFA ALDH1A1 599/4885HPGD 1242/4885KDM4E 2723/4885
US-11253596-B2 Phenylalkylcarboxylic acid delivery agents PGF, LIPA, PDGFA ALDH1A1 599/4885HPGD 1242/4885KDM4E 2723/4885
US-20160375135-A1 PHENYLALKYLCARBOXYLIC ACID DELIVERY AGENTS PGF, LIPA, PDGFA ALDH1A1 599/4885HPGD 1242/4885KDM4E 2723/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.